Altimmune, Inc. (ALT) Tops Q4 EPS by 1c

Altimmune, Inc. (NASDAQ: ALT) reported Q4 EPS of ($0.33), $0.01 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c